The Harvard Medical School International Center for Genetic Disease (HMS-iCGD) aims to enhance genomic and precision medicine globally through partnerships with governments, industry leaders, and major academic institutions. The HMS-iCGD serves as a platform focused on analyzing patients and healthy subjects from different parts of the world to research the causes and consequences, prevention, and treatment of diseases. HMS-iCGD brings together world-class clinicians and scientists, with an unmatched commitment to multidisciplinary research, cutting-edge technology, and innovative methods. We implement research, education, and translational programs to build sustainable capacity in genomic and precision medicine and genetic research, aiming to contribute to improved patient care and public health.
13 July 2025
Health Ministry launches advanced clinical training program on genomic result return in collaboration with Harvard Medical School
16 May 2024
The Department of Health – Abu Dhabi Collaborates with Harvard Medical School International Center for Genetic Disease to Advance AI and Genomics Re...
14 July 2026
The n-Lorem Foundation and the Harvard Medical School International Center for Genetic Disease (HMS-iCGD) have joined efforts to explore a collaborati...
15 June 2023
The Department of Health – Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advanc...